Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 

Change in legislation triggers race to consolidate Italian pharmacies

The price of pharmacies in Italy is soaring, HBI hears – and one new group looks to be setting the early pace in the race to create a network after legislation was passed allowing corporate ownership. Previously, pharmacy businesses could only be owned by licenced pharmacists but, on the recommendation of the Italian Competition Authority, […]

The race to genetic testing in Africa

Pan-European lab company Synlab is launching a 'wellness centre' in Nigeria three months after doors opened on a similar facility in Madrid.

Indian hospitals building fewer beds

India's hospitals have all but stopped building beds in Tier I cities in the past two years, instead investing in smaller cities. HBI explores new bed growth data. 

Ping An launches comprehensive care platform

China's biggest online healthcare services provider is moving its business model towards more personalised care with the launch of a comprehensive care online platform.

Interview: David Fernández, DomusVi Healthcare

Five years ago, DomusVi created its medicalised homecare business DomusVi Healthcare. Today, while the division only represents an estimated 0.8% of the company's Spanish operations, it presents innovative approaches to doing business.

Find Us